SCHEMBL5610641

SCHEMBL5610641

CCOc1ccc(-c2ccccc2)c(-c2cc(C(F)(F)F)c(C#N)c(=O)n2Cc2ccc(F)cc2F)c1NC(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
RXRA P19793 3/20 0.53
NR1H2 P55055 3/20 0.53
NR1H3 Q13133 3/20 0.53
PDE10A Q9Y233 12/20 0.38
RIPK3 Q9Y572 1/20 0.38
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
CYP2C9 P11712 2/20 0.35
AGTR1 P30556 1/20 0.35
AGTR2 P50052 1/20 0.35
RET P07949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5610648 0.85 RXRA (0.53) RXRANR1H2NR1H3RIPK3GRIN1
SCHEMBL2389451 0.84 RXRA (0.54) RXRANR1H2NR1H3RIPK3AGTR1
SCHEMBL2391493 0.81 RXRA (0.57) RXRANR1H2NR1H3RIPK3AGTR1
SCHEMBL2388058 0.81 RXRA (0.51) RXRANR1H2NR1H3RIPK3AGTR1
SCHEMBL2388279 0.80 RXRA (0.48) RXRANR1H2NR1H3RIPK3AGTR1
SCHEMBL2386535 0.80 RXRA (0.48) RXRANR1H2NR1H3RIPK3RET
SCHEMBL5615380 0.78 RXRA (0.58) RXRANR1H2NR1H3PDE10ARET
SCHEMBL5597884 0.78 RXRA (0.57) RXRANR1H2NR1H3PDE10AAGTR1
SCHEMBL5816750 0.77 RXRA (0.61) RXRANR1H2NR1H3RIPK3
SCHEMBL5793671 0.76 RXRA (0.61) RXRANR1H2NR1H3RIPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773337-A2 MODULATORS OF NUCLEAR RECEPTORS Exelixis, Inc. (US) 2007-04-18 EP claimed
WO-2006025979-A2 MODULATORS OF NUCLEAR RECEPTORS EXELIXIS, INC. (US) 2006-03-09 WO claimed